The DOI matches its Crossref record, with a small difference in title or year; 34 of the 34 references it cites were found in a registry or an index.
A Randomized Study of the Prevention of Sudden Death in Patients with Coronary Artery Disease
Open accessAbstract
BACKGROUND: Empirical antiarrhythmic therapy has not reduced mortality among patients with coronary artery disease and asymptomatic ventricular arrhythmias. Previous studies have suggested that antiarrhythmic therapy guided by electrophysiologic testing might reduce the risk of sudden death. METHODS: We conducted a randomized, controlled trial to test the hypothesis that electrophysiologically guided antiarrhythmic therapy would reduce the risk of sudden death among patients with coronary artery disease, a left ventricular ejection fraction of 40 percent or less, and asymptomatic, unsustained ventricular tachycardia. Patients in whom sustained ventricular tachyarrhythmias were induced by programmed stimulation were randomly assigned to receive either antiarrhythmic therapy, including drugs and implantable defibrillators, as indicated by the results of electrophysiologic testing, or no antiarrhythmic therapy. Angiotensin-converting-enzyme inhibitors and beta-adrenergic-blocking agents were administered if the patients could tolerate them. RESULTS: A total of 704 patients with inducible, sustained ventricular tachyarrhythmias were randomly assigned to treatment groups. Five-year Kaplan-Meier estimates of the incidence of the primary end point of cardiac arrest or death from arrhythmia were 25 percent among those receiving electrophysiologically guided therapy and 32 percent among the patients assigned to no antiarrhythmic therapy (relative risk, 0.73; 95 percent confidence interval, 0.53 to 0.99), representing a reduction in risk of 27 percent). The five-year estimates of overall mortality were 42 percent and 48 percent, respectively (relative risk, 0.80; 95 percent confidence interval, 0.64 to 1.01). The risk of cardiac arrest or death from arrhythmia among the patients who received treatment with defibrillators was significantly lower than that among the patients discharged without receiving defibrillator treatment (relative risk, 0.24; 95 percent confidence interval, 0.13 to 0.45; P<0.001). Neither the rate of cardiac arrest or death from arrhythmia nor the overall mortality rate was lower among the patients assigned to electrophysiologically guided therapy and treated with antiarrhythmic drugs than among the patients assigned to no antiarrhythmic therapy. CONCLUSIONS: Electrophysiologically guided antiarrhythmic therapy with implantable defibrillators, but not with antiarrhythmic drugs, reduces the risk of sudden death in high-risk patients with coronary disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Following the Multicenter Unsustained Tachycardia Trial (MUSTT) (Buxton et al., 1999), there is a role for AECG for NSVT detection in post-MI patients with LVEF 35%-40% as electrophysiologically guided ICD implantation improves survival”
From 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry (2017) · cites this paper as Buxton et al., 1999
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“NSVT accompanied by inducibility of sustained VT during programmed ventricular stimulation was associated with an increased risk of SCD”
From 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry (2017) · cites this paper as Buxton et al., 1999
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
The Statistical Analysis of Failure Time Data.
Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo
Echt, D. S., Liebson, P. R., Mitchell, L. B., Peters, R. W., Obias-Manno, D., Barker, A. H., Arensberg, D., Baker, A., Friedman, L., Greene, H. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241201 · Cited by 3,244
The AVID Investigators (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,221
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Julian, D. G., CAMM, A. J., Frangin, G., Janse, M. J., Munoz, A., Pj, S., & Simon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09145-3 · Cited by 1,100
Cairns, J. A., Connolly, S. J., Roberts, R. E., & Gent, M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)08171-8 · Cited by 949
de Vreede-Swagemakers, J. J. M., Gorgels, A. P. M., Dubois-Arbouw, W. I., van Ree, J. W., Daemen, M. J. A. P., Houben, L. G. E., & Wellens, H. J. J. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00355-0 · Cited by 841
Clinical classification of cardiac deaths.
Hinkle, L. E., & Thaler, H. T. (1982) · Circulation · doi:10.1161/01.cir.65.3.457 · Cited by 640
Use of the Automatic External Defibrillator in the Management of Out-of-Hospital Cardiac Arrest
Weaver, W. D., Hill, D., Fahrenbruch, C. E., Copass, M. K., Martin, J. S., Cobb, L. A., & Hallstrom, A. P. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809153191101 · Cited by 473
Prehospital Ventricular Defibrillation
Liberthson, R. R., Nagel, E. L., Hirschman, J. C., & Nussenfeld, S. R. (1974) · New England Journal of Medicine · doi:10.1056/nejm197408152910701 · Cited by 472
Denniss, A. R., Richards, D. A., Cody, D. V., Russell, P. A., Young, A. A., Cooper, M. J., Ross, D. L., & Uther, J. B. (1986) · Circulation · doi:10.1161/01.cir.74.4.731 · Cited by 450
Racial Differences in the Incidence of Cardiac Arrest and Subsequent Survival
Becker, L. B., Han, B. H., Meyer, P., Wright, F. A., Rhodes, K. V., Smith, D. W., & Barrett, J. A. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308263290902 · Cited by 441
Wilber, D. J., Olshansky, B., Moran, J. F., & Scanlon, P. J. (1990) · Circulation · doi:10.1161/01.cir.82.2.350 · Cited by 274
Rouleau, J. L., Talajic, M. R., Sussex, B. A., Potvin, L., Warnica, W. J., Davies, R. F., Gardner, M., Stewart, D. J., Planté, S., Dupuis, R., et al. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00599-4 · Cited by 268
Simoons, M. L., Vos, J., Tijssen, J. G. P., Vermeer, F., Verheugt, F. W. A., Krauss, X. H., & Cats, V. M. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90003-x · Cited by 220
Buxton, A. E., Fisher, J. D., Josephson, M. E., Lee, K. L., Pryor, D. B., Prystowsky, E. N., Simson, M. B., DiCarlo, L. A., Echt, D. S., Packer, D. L., et al. (1993) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(93)90015-6 · Cited by 180
Self-citationGomes, J. A., Hariman, R. I., Kang, P. S., El-Sherif, N., Chowdhry, I. H., & Lyons, J. (1984) · Circulation · doi:10.1161/01.cir.70.1.43 · Cited by 165
Bourke, J. P., Richards, D. A. B., Ross, D. L., Wallace, E. M., McGuire, M. A., & Uther, J. B. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90802-g · Cited by 161
Programmed ventricular stimulation in survivors of an acute myocardial infarction.
Roy, D., Marchand, E., Théroux, P., Waters, D. D., Pelletier, G. B., & Bourassa, M. G. (1985) · Circulation · doi:10.1161/01.cir.72.3.487 · Cited by 142
Buxton, A. E., Marchlinski, F. E., Flores, B. T., Miller, J. M., Doherty, J. U., & Josephson, M. E. (1987) · Circulation · doi:10.1161/01.cir.75.6.1178 · Cited by 131
Self-citationCerqueira, M. D., Maynard, C. C., Ritchie, J. L., Davis, K. B., & Kennedy, J. W. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90436-q · Cited by 104
Denes, P., Gillis, A. M., Yudi Pawitan, Y., Kammerling, J. M., Wilhelmsen, L., Salerno, D. M., & The CAST Investigators (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90404-9 · Cited by 71
Buxton, A. E., Hafley, G. E., Lehmann, M. H., Gold, M. R., O’Toole, M., Tang, A., Coromilas, J., Hook, B. G., Stamato, N. J., & Lee, K. L. (1999) · Circulation · doi:10.1161/01.cir.99.14.1843 · Cited by 70
Self-citationIesaka, Y., Nogami, A., Aonuma, K., Nitta, J., Chun, Y., Fujiwara, H., & Hiraoka, M. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90314-q · Cited by 61
Klein, J., Froelicher, V. F., Detrano, R., Dubach, P., & Yen, R. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90178-2 · Cited by 52
Buxton, A. E., Lee, K. L., DiCarlo, L., Echt, D. S., Fisher, J. D., Greer, G. S., Josephson, M. E., Packer, D., Prystowsky, E. N., Talajic, M. R., et al. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00006 · Cited by 50
Self-citationTavazzi, L., & Volpi, A. (1997) · Circulation · doi:10.1161/01.cir.95.5.1341 · Cited by 44
Mitchell, L. B., Sheldon, R. S., Gillis, A. M., Connolly, S. J., Duff, H. J., Gardner, M. J., Hui, W. K. K., Ramadan, D., & Wyse, D. G. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00294-5 · Cited by 23
Meta-analysis of empirical long-term antiarrhythmic therapy after myocardial infarction
Hine, L. K. (1989) · JAMA · doi:10.1001/jama.262.21.3037 · Cited by 9
Research works printed but not linked: 1
- 10.2307/2281868 · DOI · Paper page
Cited by
Sorted by citations
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
“symptoms while receiving GDMT, who have reasonable expectation of meaningful survival for more than 1 yeary (362,597,598).”
BackgroundMoss, A. J., Zaręba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,885
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
Dickstein, K., Authors Task Force Members, Solal, A. C., Filippatos, G. S., McMurray, J. J. V., Ponikowski, P. P., Poole-Wilson, P. A., Strömberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.08.005 · Cited by 3,532
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8807 · Cited by 3,304
Zeppenfeld, K., Tfelt‐Hansen, J., Riva, M., Winkel, B. G., Behr, E. R., Blom, N. A., Charron, P., Corrado, D., Dagres, N., de Chillou, C., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac262 · Cited by 3,432
Metadata
- Authors
- Buxton, A. E., Lee, K. L., Fisher, J. D., Josephson, M. E., Prystowsky, E. N., & Hafley, G.
- Affiliations
- Brown University (US)
- Duke University (US)
- Albert Einstein College of Medicine (US)
- Beth Israel Deaconess Medical Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1999-12-16
- Volume
- 341
- Issue
- 25
- Pages
- 1882-1890
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2313547185
- Cited by
- 2,489
- References
- 34
- Citations by year
- 2026: 20 · 2025: 36 · 2024: 23 · 2023: 34 · 2022: 44 · 2021: 41 · 2020: 51 · 2019: 54 · 2018: 54 · 2017: 92 · 2016: 75 · 2015: 87 · 2014: 95 · 2013: 114 · 2012: 122
- FWCI
- 70.29
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5u01hl045726-06)
- National Heart, Lung, and Blood Institute (UO1HL45700, UO1-HL45726, U01HL045700)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Keywords
- coronary artery disease, asymptomatic ventricular arrhythmia, implantable cardioverter-defibrillator, antiarrhythmic drugs, electrophysiologic testing, programmed electrical stimulation, cardiac arrest, all-cause mortality, left ventricular ejection fraction, ACE inhibitors, beta-blockers
- MeSH terms
- Aged, Anti-Arrhythmia Agents, Cardiac Pacing, Artificial, Coronary Disease, Electrophysiology, Female, Humans, Male, Middle Aged, Survival Analysis, Death, Sudden, Cardiac, Defibrillators, Implantable, Tachycardia, Ventricular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review